Болезнь Лайма

Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice puidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.Полный текст  Аннотация

Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis. 2003 Aug;3(8):489-500. Аннотация

Steere AC. Lyme disease. N Engl J Med. 2001 Jul 12;345(2):115-25. Аннотация

Stanek G, Strle F. Lyme borreliosis. Lancet. 2003 Nov 15;362(9396):1639-47. Аннотация

Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004 Apr;113(8):1093-101.Полный текст  Аннотация

Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005 Jul;18(3):484-509.Полный текст  Аннотация

Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect. 2004;10:598-614. Аннотация

Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med. 2003 Jun 12;348(24):2424-30. Аннотация

Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1.Полный текст  Аннотация

National Institute for Health and Care Excellence (UK). Lyme disease. October 2018 [internet publication].Полный текст

1. Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007 Jun 20;297(23):2617-27. Аннотация

2. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice puidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.Полный текст  Аннотация

3. Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis. 2003 Aug;3(8):489-500. Аннотация

4. Steere AC. Lyme disease. N Engl J Med. 2001 Jul 12;345(2):115-25. Аннотация

5. Nau R, Christen HJ, Eiffert H. Lyme disease: current state of knowledge. Dtsch Arztebl Int. 2009 Jan;106(5):72-81;quiz 82, I.Полный текст  Аннотация

6. Schwartz AM, Hinckley AF, Mead PS, et al. Surveillance for Lyme disease - United States, 2008-2015. MMWR Surveill Summ. 2017 Nov 10;66(22):1-12.Полный текст  Аннотация

7. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003 Nov 15;362(9396):1639-47. Аннотация

8. Bennet L, Halling A, Berglund J. Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers. Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):426-32. Аннотация

9. Centers for Disease Control and Prevention. Tickborne disease surveillance data summary. November 2019 [internet publication].Полный текст

10. Centers for Disease Control and Prevention. How many people get Lyme disease? December 2018 [internet publication].Полный текст

11. Adams DA, Thomas KR, Jajosky RA, et al. Summary of notifiable infectious diseases and conditions - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017 Aug 11;64(53):1-143.Полный текст  Аннотация

12. Zhang X, Meltzer MI, Pena CA, et al. Economic impact of Lyme disease. Emerg Infect Dis. 2006 Apr;12(4):653-60.Полный текст  Аннотация

13. Groseclose SL, Brathwaite WS, Hall PA, et al. Summary of notifiable diseases - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004 Apr 30;51(53):1-84.Полный текст  Аннотация

14. Steere AC, McHugh G, Suarez C, et al. Prospective study of coinfection in patients with erythema migrans. Clin Infect Dis. 2003 Apr 15;36(8):1078-81.Полный текст  Аннотация

15. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004 Apr;113(8):1093-101.Полный текст  Аннотация

16. Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005 Jul;18(3):484-509.Полный текст  Аннотация

17. Pritt BS, Mead PS, Johnson DK, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016 May;16(5):556-64.Полный текст  Аннотация

18. Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect. 2004;10:598-614. Аннотация

19. Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med. 2003 Jun 12;348(24):2424-30. Аннотация

20. Daltroy LH, Phillips C, Lew R, et al. A controlled trial of a novel primary prevention program for Lyme disease and other tick-borne illnesses. Health Educ Behav. 2007 Jun;34(3):531-42. Аннотация

21. Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008 May;83(5):566-71.Полный текст  Аннотация

22. Dessau RB, van Dam AP, Fingerle V, et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect. 2018 Feb;24(2):118-24.Полный текст  Аннотация

23. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1.Полный текст  Аннотация

24. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of lyme disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Полный текст  Аннотация

25. National Institute for Health and Care Excellence (UK). Lyme disease. October 2018 [internet publication].Полный текст

26. Mygland A, Ljøstad U, Fingerle V, et al; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010 Jan;17(1):8-16;e1-4.Полный текст  Аннотация

27. Moore A, Nelson C, Molins C, et al. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States. Emerg Infect Dis. 2016 Jul;22(7):1169–77.Полный текст  Аннотация

28. Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021 Jan 27 [Epub ahead of print]. Аннотация

29. American Academy of Pediatrics. Lyme disease. In: Kimberlin DW, Brady MT, Jackson MA, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018: 515-23.

30. American Academy of Pediatrics. Tetracyclines. In: Kimberlin DW, Brady MT, Jackson MA, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018: 905-6.

31. Steere AC, Malawista SE, Newman JH, et al. Antibiotic therapy in Lyme disease. Ann Intern Med. 1980 Jul;93(1):1-8. Аннотация

32. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of early manifestations of Lyme disease. Ann Intern Med. 1983 Jul;99(1):22-6. Аннотация

33. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med. 1992 Apr;92(4):396-403. Аннотация

34. Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med. 1992 Aug 15;117(4):273-80. Аннотация

35. Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995 Mar;39(3):661-7.Полный текст  Аннотация

36. Nowakowski J, Nadelman RB, Forseter G, et al. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):223-7. Аннотация

37. Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics. 2002 Jun;109(6):1173-7. Аннотация

38. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 May 6;138(9):697-704. Аннотация

39. Sigal LH. Early disseminated Lyme disease: cardiac manifestations. Am J Med. 1995 Apr 24;98(4A):25S-28S;discussion 28S-29S. Аннотация

40. Berende A, Ter Hofstede HJM, Vos FJ, et al. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis. Neurology. 2019 Mar 26;92(13):e1447-55.Полный текст  Аннотация

41. Waddell LA, Greig J, Lindsay LR, et al. A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PLoS One. 2018 Nov 12;13(11):e0207067.Полный текст  Аннотация

42. Lathrop SL, Ball R, Haber P, et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine. 2002 Feb 22;20(11-12):1603-8. Аннотация

43. Nadelman RB, Nowakowski J, Fish D, et al; Tick Bite Study Group. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001 Jul 12;345(2):79-84.Полный текст  Аннотация

44. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994 Jun;37(6):878-88. Аннотация

45. Eckman MH, Steere AC, Kalish RA, et al. Cost effectiveness of oral as compared with intravenous antibiotic treatment for patients with early Lyme disease or Lyme arthritis. N Engl J Med. 1997 Jul 31;337(5):357-63.Полный текст  Аннотация

46. Nemeth J, Bernasconi E, Heininger U, et al. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly. 2016 Dec 5;146:w14353.Полный текст  Аннотация

47. Eliassen KE, Hjetland R, Reiso H, et al. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice. Scand J Prim Health Care. 2017 Mar;35(1):75-83.Полный текст  Аннотация

48. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374:1209-1220.Полный текст  Аннотация

49. Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. AAnn Intern Med. 1983 Dec;99(6):767-72. Аннотация

50. Dotevall L, Alestig K, Hanner P, et al. The use of doxycycline in nervous system Borrelia burgdorferi infection. Scand J Infect Dis Suppl. 1988;53:74-9. Аннотация

51. Pfister HW, Preac-Mursic V, Wilske B, et al. Cefotaxime vs. penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol. 1989 Nov;46(11):1190-4. Аннотация

52. Mullegger RR, Millner MM, Stanek G, et al. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children - a prospective study. Infection. 1991 Jul-Aug;19(4):279-83. Аннотация

53. Pfister HW, Preac-Mursic V, Wilske B, et al. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis. 1991 Feb;163(2):311-8. Аннотация

54. Wormser GP. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination. Semin Neurol. 1997 Mar;17(1):45-52. Аннотация

55. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis. 1999 Mar;28(3):569-74.Полный текст  Аннотация

56. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology. 1994 Jul;44(7):1203-7. Аннотация

57. Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis: randomized comparison of doxycycline and penicillin G. J Neurol. 1989 Dec;236(8):464-9. Аннотация

58. Thorstrand C, Belfrage E, Bennet R, et al. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J. 2002 Dec;21(12):1142-5. Аннотация

59. Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis. 2005;37(6-7):449-54. Аннотация

60. Karkkonen K, Stiernstedt SH, Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme borreliosis. Scand J Infect Dis. 2001;33(4):259-62. Аннотация

61. Dattwyler RJ, Halperin JJ, Volkman DJ, et al. Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet. 1988 May 28;1(8596):1191-4. Аннотация

62. Dattwyler RJ, Wormser GP, Rush TJ, et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr. 2005 Jun;117(11-12):393-7. Аннотация

63. Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am. 2002 Mar;86(2):285-96. Аннотация

64. Strle F, Maraspin V, Pleterski-Rigler D, et al. Treatment of borrelial lymphocytoma. Infection. 1996 Jan-Feb;24(1):80-4. Аннотация

65. Marzec NS, Nelson C, Waldron PR, et al. Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease - United States. MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):607-9.Полный текст  Аннотация